An Implementation Science Study Investigating Profiles of Men Interested in MMC
NCT ID: NCT02352961
Last Updated: 2016-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2817 participants
OBSERVATIONAL
2014-04-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya
NCT02497989
Information About HIV Transmission and Circumcision on Subsequent Sexual Behavior, and the Demand for Circumcision
NCT01895556
Effect of Male Circumcision on HIV Incidence (ANRS 1265)
NCT00122525
Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
NCT00623051
Uptake of Medical Male Circumcision Among Men With Sexually Transmitted Infections
NCT04677374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Part II (Intervention Period) Findings from the formative period will be used to develop interventions to increase the ratio of men (25-49 years)mature, or at least of higher risk men, undergoing MMC at the clinic. During this proposed intervention period we would like to evaluate the effectiveness of those interventions and the outcomes related to them. These proposed interventions will directly address the barriers to MMC that challenge uptake of MMC among mature men (25-49 years). Additionally, epidemiologic research will be conducted among men attending our MMC clinic to evaluate whether mature men (25-49 years) exhibit, as is presumed, higher risk profiles for HIV. We will also explore the cost-effectiveness of this strategy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exclusive Intervention Strategy
The "Exclusive Intervention Strategy" aimed at men aged 25 - 49 years and "Active Follow-up strategy"
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are aged 18 years or older (no upper age limit)
* Have never been completely medically circumcised (as opposed to partial circumcision)
* Willing and able to give their written informed consent so that the information collected during the clinic visit can be analysed for research purposes.
All males who meet the following criteria will be eligible for inclusion:
* Present at Aurum's male circumcision clinic during the cross sectional component or men who indicate no interest in medical male circumcision
* Are between the ages of 25 and 49 inclusive
* Are not circumcised at the time of the interview as assessed through visual examination
* Is willing and able to provide written informed consent.
* Willing for the qualitative session to be tape recorded
* Are 18 and above (no upper age limit)
* Has a partner who is participating in the cross sectional component, is not in a relationship but lives in the vicinity of Ekurhuleni North district or is part of a women's organization within the community where the clinic is located
* Is willing and able to provide written informed consent
* Willing for the qualitative session to be tape recorded
* Are between the ages 25 and 49 years inclusive
* Has never been medically circumcised
* Is willing and able to provide written informed consent
* Are between the ages 25 and 49 years inclusive
* Has never been medically circumcised
* Is willing and able to provide written informed consent
* Has contra-indication/s to MMC on the day of presentation for MMC
* Is willing to provide contact information for retention
Exclusion Criteria
* Men and women who do not in the opinion of staff obtaining consent have the capacity to provide written informed consent will be excluded from the research.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
The Aurum Institute NPC
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Salome Charalambous, MBBCH, PhD
Role: PRINCIPAL_INVESTIGATOR
Aurum Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Aurum Institute
Gauteng, Gauteng, South Africa
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chetty-Makkan CM, Grund JM, Muchiri E, Price MA, Latka MH, Charalambous S. High risk sexual behaviours associated with traditional beliefs about gender roles among men interested in medical male circumcision in South Africa. AIDS Res Ther. 2021 Jun 22;18(1):33. doi: 10.1186/s12981-021-00359-7.
Grund JM, Chetty-Makkan CM, Ginindza S, Munyai R, Kisbey-Green H, Maraisane M, Charalambous S. Effectiveness of an "Exclusive Intervention Strategy" to increase medical male circumcision uptake among men aged 25-49 years in South Africa. BMC Public Health. 2018 Jul 13;18(1):868. doi: 10.1186/s12889-018-5729-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUR2-4-121
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.